Preliminary studies using vemurafenib, an inhibitor of BRAF harboring the V600E mutation, has shown promising results, mainly in refractory cases.1,3,6,13 In cases of localized brain involvement with meningioma-like tumors, surgical resection should be considered. Here, BRAF is linked to meningioma.